Sabra Health Care REIT, Inc.
For the period ended Jun 30, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 3, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Trading Arrangements
On June 8, 2026, Richard K. Matros, our Chief Executive Officer, President and Chair of our Board of Directors, adopted a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (the “Rule 10b5-1 Plan”). The Rule 10b5-1 Plan provides for the potential sale of 200,000 shares of the Company’s common stock commencing September 8, 2026. The Rule 10b5-1 Plan terminates on the earlier of March 10, 2027 or the date all shares are sold.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.